180 related articles for article (PubMed ID: 22549684)
1. P53 and bcl-2 immunoexpression in patients with oral lichen planus and oral squamous cell carcinoma.
Leyva-Huerta ER; Ledesma-Montes C; Rojo-Botello RE; Vega-Memije E
Med Oral Patol Oral Cir Bucal; 2012 Sep; 17(5):e745-50. PubMed ID: 22549684
[TBL] [Abstract][Full Text] [Related]
2. Oral lichen planus shows higher expressions of tumor suppressor gene products of p53 and p21 compared to oral mucositis. An immunohistochemical study.
Safadi RA; Al Jaber SZ; Hammad HM; Hamasha AA
Arch Oral Biol; 2010 Jun; 55(6):454-61. PubMed ID: 20427035
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of the expression of proliferating cell nuclear antigen, p53, bax, and bcl-2 in oral lichen planus and oral squamous cell carcinoma.
de Sousa FA; Paradella TC; Carvalho YR; Rosa LE
Ann Diagn Pathol; 2009 Oct; 13(5):308-12. PubMed ID: 19751907
[TBL] [Abstract][Full Text] [Related]
4. CD133 expression in oral lichen planus correlated with the risk for progression to oral squamous cell carcinoma.
Sun L; Feng J; Ma L; Liu W; Zhou Z
Ann Diagn Pathol; 2013 Dec; 17(6):486-9. PubMed ID: 23911820
[TBL] [Abstract][Full Text] [Related]
5. Bmi1 expression in oral lichen planus and the risk of progression to oral squamous cell carcinoma.
Ma L; Wang H; Yao H; Zhu L; Liu W; Zhou Z
Ann Diagn Pathol; 2013 Aug; 17(4):327-30. PubMed ID: 23639414
[TBL] [Abstract][Full Text] [Related]
6. Higher expressions of p53 and proliferating cell nuclear antigen (PCNA) in atrophic oral lichen planus and patients with areca quid chewing.
Lee JJ; Kuo MY; Cheng SJ; Chiang CP; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Apr; 99(4):471-8. PubMed ID: 15772596
[TBL] [Abstract][Full Text] [Related]
7. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study.
Sudha VM; Hemavathy S
Indian J Dent Res; 2011; 22(4):520-5. PubMed ID: 22124045
[TBL] [Abstract][Full Text] [Related]
8. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.
Ogmundsdóttir HM; Björnsson J; Holbrook WP
J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450
[TBL] [Abstract][Full Text] [Related]
9. Sequential immunohistochemical p53 expression in biopsies of oral lichen planus undergoing malignant evolution.
Valente G; Pagano M; Carrozzo M; Carbone M; Bobba V; Palestro G; Gandolfo S
J Oral Pathol Med; 2001 Mar; 30(3):135-40. PubMed ID: 11271627
[TBL] [Abstract][Full Text] [Related]
10. Unstimulated salivary p53 in patients with oral lichen planus and squamous cell carcinoma.
Agha-Hosseini F; Mirzaii-Dizgah I; Miri-Zarandi N
Acta Med Iran; 2015 Jul; 53(7):439-43. PubMed ID: 26520632
[TBL] [Abstract][Full Text] [Related]
11. Metabolic changes during malignant transformation in primary cells of oral lichen planus: Succinate accumulation and tumour suppression.
Yang Q; Sun H; Wang X; Yu X; Zhang J; Guo B; Hexige S
J Cell Mol Med; 2020 Jan; 24(2):1179-1188. PubMed ID: 31793175
[TBL] [Abstract][Full Text] [Related]
12. Salivary basic fibroblast growth factor in patients with oral squamous cell carcinoma or oral lichen planus.
Gorugantula LM; Rees T; Plemons J; Chen HS; Cheng YS
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Aug; 114(2):215-22. PubMed ID: 22769407
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of proliferative potential in oral lichen planus and oral lichenoid lesions using immunohistochemical expression of p53 and Ki67.
Acay RR; Felizzola CR; de Araújo N; de Sousa SO
Oral Oncol; 2006 May; 42(5):475-80. PubMed ID: 16364678
[TBL] [Abstract][Full Text] [Related]
14. Caveolin-1 expression in oral lichen planus, dysplastic lesions and squamous cell carcinoma.
Jaafari-Ashkavandi Z; Aslani E
Pathol Res Pract; 2017 Jul; 213(7):809-814. PubMed ID: 28554768
[TBL] [Abstract][Full Text] [Related]
15. Comparison of p53, HSP90, E-cadherin and HPV in oral lichen planus and oral squamous cell carcinoma.
Bar JK; Cierpikowski P; Lis-Nawara A; Duc P; Hałoń A; Radwan-Oczko M
Acta Otorhinolaryngol Ital; 2021 Dec; 41(6):514-522. PubMed ID: 34928263
[TBL] [Abstract][Full Text] [Related]
16. Expression of small leucine-rich extracellular matrix proteoglycans biglycan and lumican reveals oral lichen planus malignant potential.
Lončar-Brzak B; Klobučar M; Veliki-Dalić I; Sabol I; Kraljević Pavelić S; Krušlin B; Mravak-Stipetić M
Clin Oral Investig; 2018 Mar; 22(2):1071-1082. PubMed ID: 28779221
[TBL] [Abstract][Full Text] [Related]
17. Valuation of exfoliative cytology as prediction factor in oral mucosa lesions.
Brunotto M; Zárate AM; Cismondi A; Fernández Mdel C; Noher de Halac RI
Med Oral Patol Oral Cir Bucal; 2005 Jul; 10 Suppl 2():E92-102. PubMed ID: 15995578
[TBL] [Abstract][Full Text] [Related]
18. CD146 expression in oral lichen planus and oral cancer.
Pariyawathee S; Phattarataratip E; Thongprasom K
Clin Oral Investig; 2020 Jan; 24(1):325-332. PubMed ID: 31102047
[TBL] [Abstract][Full Text] [Related]
19. [The expression of apoptosis-associated proteins Bcl-2, Bax in oral leukoplakia and lichen planus].
Fan Y; Zhan Z; Peng T; Song XL; Feng ZQ
Shanghai Kou Qiang Yi Xue; 2004 Dec; 13(6):497-501. PubMed ID: 15619691
[TBL] [Abstract][Full Text] [Related]
20. Comparison of B-Cell Activating Factor Expression in Neutrophils in Patients with Potentially Malignant Disorders and Patients with Cancer in the Same Site.
Jab O Ska E; S Odczyk BE; Wawrusiewicz-Kurylonek N; Dziemia Czyk-Pakie A D; Garley M; Ratajczak-Wrona W; Borys J; Kr Towski A
Clin Lab; 2016 Aug; 62(8):1507-1514. PubMed ID: 28164620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
